We confirmed that hepatic AEBP1 expression is elevated in fibrosis compared to lobular inflammation, steatosis, and normal liver, and increases with worsening fibrosis in NASH patients. The gene discussed is AEBP1; the disease is metabolic dysfunction-associated steatohepatitis.